Compare Amgen, Inc. (AMGN) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs Peloton Interactive Inc — how do they compare? Amgen, Inc. trades at $363.55 (market cap $196.12B), while Peloton Interactive Inc trades at $5.83 (market cap $2.54B). The key difference: Amgen, Inc. is far larger — about 77.2× Peloton Interactive Inc's market cap, and Amgen, Inc. pays a 2.77% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals.
| AMGN | PTON | |
|---|---|---|
Market Cap | $196.12B | $2.54B |
Sector | Health | Consumer Cyclical |
52-Week High | $388.16 | $9.00 |
52-Week Low | $271.18 | $3.71 |
Enterprise Value | $241.41B | $3.14B |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Peloton Interactive (PTON) trades at $5.86, down 1.35% on the day, showing signs of stabilization after a 96% decline from pandemic highs. The company reported positive operating cash flow of $333M in 2025 and is projected to achieve profitability in 2026 with $23M net income. Technical indicators show a bullish moving average trend while fundamentals reveal improving margins and declining losses, though the stock carries a high P/E ratio of 97.83. Recent developments include inclusion in the S&P SmallCap 600 index and appointment of a new CFO.
PTON presents a turnaround opportunity with improving cash flow and projected profitability, but faces significant execution risks amid declining revenue and negative shareholder equity. Analyst consensus is cautiously optimistic with a $7.50 price target representing 28% upside, though the company must demonstrate sustainable subscriber growth to justify current valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
